BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 11444857)

  • 1. DNA mismatch repair enzyme activity and gene expression in prostate cancer.
    Yeh CC; Lee C; Dahiya R
    Biochem Biophys Res Commun; 2001 Jul; 285(2):409-13. PubMed ID: 11444857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
    Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects of DNA mismatch repair in human prostate cancer.
    Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
    Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair and microsatellite instability in esophageal cancer cells.
    Uchida N; Kumimoto H; Nishizawa K; Tokumasu S; Harada H; Shimada Y; Ishizaki K
    Int J Cancer; 2001 Mar; 91(5):687-91. PubMed ID: 11267981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of human mismatch repair genes in adult T-cell leukemia.
    Morimoto H; Tsukada J; Kominato Y; Tanaka Y
    Am J Hematol; 2005 Feb; 78(2):100-7. PubMed ID: 15682421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of mismatch repair activity in simian virus 40 large T antigen-immortalized BPH-1 human prostatic epithelial cell line.
    Yeh CC; Lee C; Huang MC; Dahiya R
    Mol Carcinog; 2001 Jul; 31(3):145-51. PubMed ID: 11479923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells.
    Balogh GA; Russo IH; Russo J
    Int J Oncol; 2003 Aug; 23(2):411-9. PubMed ID: 12851690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants.
    Brieger A; Trojan J; Raedle J; Plotz G; Zeuzem S
    Gut; 2002 Nov; 51(5):677-84. PubMed ID: 12377806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines.
    Yao Y; Tao H; Kim JJ; Burkhead B; Carloni E; Gasbarrini A; Sepulveda AR
    Lab Invest; 2004 Jul; 84(7):915-22. PubMed ID: 15133479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.
    Rigau V; Sebbagh N; Olschwang S; Paraf F; Mourra N; Parc Y; Flejou JF
    Arch Pathol Lab Med; 2003 Jun; 127(6):694-700. PubMed ID: 12741892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
    Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
    Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
    Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
    Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells.
    Leung WK; Kim JJ; Wu L; Sepulveda JL; Sepulveda AR
    J Biol Chem; 2000 May; 275(21):15728-32. PubMed ID: 10748105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
    Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
    Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability testing in colorectal carcinoma: choice of markers affects sensitivity of detection of mismatch repair-deficient tumors.
    Hatch SB; Lightfoot HM; Garwacki CP; Moore DT; Calvo BF; Woosley JT; Sciarrotta J; Funkhouser WK; Farber RA
    Clin Cancer Res; 2005 Mar; 11(6):2180-7. PubMed ID: 15788665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress inactivates the human DNA mismatch repair system.
    Chang CL; Marra G; Chauhan DP; Ha HT; Chang DK; Ricciardiello L; Randolph A; Carethers JM; Boland CR
    Am J Physiol Cell Physiol; 2002 Jul; 283(1):C148-54. PubMed ID: 12055083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck.
    Nunn J; Nagini S; Risk JM; Prime W; Maloney P; Liloglou T; Jones AS; Rogers SR; Gosney JR; Woolgar J; Field JK
    Oral Oncol; 2003 Feb; 39(2):115-29. PubMed ID: 12509964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.